Schuessler cell salts

1. Introduction

Version followed: the twelve "Funktionsmittel" of Schüßler's "Biochemie" as described in German pharmacy-history and pharmacy-practice sources (Govi-Verlag chapter, PTAheute, apotheken.de), with the later 15 "Ergänzungsmittel" (Nos. 13–27) noted as additions by followers. The Biochemischer Bund Deutschlands' own publications are not cited here [uncertain: not verified]. The psychotherapist works alongside this method and does not perform, sell, prescribe or recommend the salts; section 4 is the therapist's own work when a client uses them.

What it is. Wilhelm Heinrich Schüßler (1821–1898), a homeopathic physician in Oldenburg, reported in 1873 in the Allgemeine Homöopathische Zeitung that he now treated with only twelve tissue ("cell") salts, under the title "Eine abgekürzte Therapie, gegründet auf Histologie und Cellularpathologie" [source: GWUP brochure; Govi chapter]. One pharmacy-trade article dates his main work to 1878 [source: PTAheute] [uncertain: dates differ between first article (1873), booklet (1875, per GWUP) and later editions]. He called the method "Biochemie" and distinguished it from homeopathy because it does not use the similarity principle [source: PTAheute].

Core idea of change, as the method holds it. Illness is attributed to a disturbed balance or lack of particular mineral salts in body cells; supplying the relevant salt in a highly diluted form is said to restore cell function and activate self-healing [source: GWUP; PTAheute; apotheken.de]. Schüßler drew on Moleschott's physiology and Virchow's cellular pathology, and aimed to create a "sharply limited" therapy with few remedies [source: Govi chapter]. Some descriptions attribute the effect to a "subtle vibration" ("feinstoffliche Schwingung") that Schüßler did not explain [source: Apotheken Umschau]. These are the method's own claims, stated here as attributed.

The salts (names only). Nos. 1–12: Calcium fluoratum, Calcium phosphoricum, Ferrum phosphoricum, Kalium chloratum, Kalium phosphoricum, Kalium sulfuricum, Magnesium phosphoricum, Natrium chloratum, Natrium phosphoricum, Natrium sulfuricum, Silicea, Calcium sulfuricum [source: PTAheute; apotheken.de]. Schüßler at times thought he could do without No. 12; one source says he removed it in 1895, another that it was never formally removed [source: GWUP vs Govi chapter] [uncertain]. Nos. 13–27 ("Ergänzungsmittel") were added after Schüßler by followers (one source names Dieter Schöpwinkel for the first nine by 1923) [source: Govi chapter; GWUP; apotheken.de]. A further set attributed to Joachim Broy is mentioned but not listed in the sources [source: apotheken.de].

Products and what a client experiences. Salts are prepared under the homeopathic pharmacopoeia rules (triturated with lactose and pressed into tablets) and are sold as tablets, drops and globules; they are taken dissolved slowly in the mouth [source: Govi chapter; apotheken.de; PTAheute]. A client typically self-selects in a pharmacy or online, or is advised by a pharmacy team member or another practitioner; some practitioners "read" the face (Antlitzanalyse: facial colour and lines) to choose a salt [source: Apotheken Umschau]. Schüßler linked deficiencies to facial "signatures"; Kurt Hickethier later expanded face reading into a lay system [source: GWUP]. Another source says Schüßler's own diagnostics centred on tongue coating and that face reading entered with Schöpwinkel's later system [source: Govi chapter] [uncertain: sources differ]. Leaflets mention a possible temporary worsening of existing complaints ("initial aggravation") and say to stop and ask a doctor if it occurs [source: DHU leaflet].

Who practises. In Germany, mainly self-care via pharmacies and drugstores; pharmacy staff can take commercial trainings (e.g. an IHK-examined "Fachberater" course for pharmacy technicians run by a Schüßler institute in cooperation with a manufacturer, reported in 2015) [source: apotheke adhoc]. Use by Heilpraktiker and lay associations: the first Biochemischer Verein was founded in Oldenburg in 1885, and associations were merged into the Biochemischer Bund Deutschlands in 1922, which still exists [source: GWUP; Govi chapter]. Elsewhere, sold as "tissue salts" or "cell salts" [source: MHRA].

Regulation, one line each.

• Germany: sold as registered homeopathic medicinal products, "therefore without a stated therapeutic indication" (leaflet wording, paraphrased) [source: DHU leaflet]. Pharmacy-only vs general-sale status not verified [uncertain: not verified].
• UK: MHRA treats tissue/Schüssler salts as medicinal products when promoted as homeopathic, with a potency value or with medical indications, and has required websites to change such advertising [source: MHRA 2015].
• USA: homeopathic drug products are marketed without the required FDA approval; FDA prioritises enforcement on a risk basis (final guidance, December 2022) [source: FDA guidance page].
• Other jurisdictions: [uncertain: not verified].

Evidence status, one line. German consumer and medical sources state there is no recognised clinical study showing an effect [source: Apotheken Umschau; BARMER]; Stiftung Warentest and the Austrian Cochrane team are reported as judging benefit unproven and the concept implausible [source: GWUP, secondary report].

2. Framework

There is no psychotherapeutic protocol for Schüßler salts. The framework below organises the therapist's alongside work; it is [synthesis] built on the description of the method in sections 1–3 and the risks named in the sources. It is woven into ongoing therapy rather than run as a separate course; most clients need one focused conversation plus brief check-ins, more if risk or health anxiety is present [synthesis].

Phases are not strictly sequential: any red flag (phase E) overrides the order [synthesis].

3. Guiding principles

• Never perform, sell, prescribe or recommend. Practical meaning: you do not choose salts, read faces, suggest products or endorse a practitioner; you discuss decisions, not remedies [synthesis; APA 2.01, 3.06].
• Curiosity before information. Ask what the salts mean before saying anything about evidence [synthesis].
• Attribute, do not adjudicate. Describe the method's claims as the method's ("in Schüßler's system…"), neither as fact nor with ridicule [synthesis].
• Accurate, sourced information only. If asked, give the regulatory and evidence status as public bodies state it, citing the source; do not improvise [synthesis; APA 2.04].
• Autonomy with safety. Adults may choose complementary products; your duty is informed choice and attention to harm, especially delayed medical care [synthesis; APA 3.04, 3.10].
• Medicines belong to prescribers. Never advise starting, stopping or changing a medicine or remedy; route to the doctor or pharmacist [synthesis; leaflet advises asking a doctor or pharmacist about other medicines: DHU leaflet].
• Coordinate with consent. Share only what the client agrees to, except where law or safeguarding requires otherwise [APA 3.09, 4.05].
• Watch the body's alarm signals, not the remedy. New, persistent, worsening or unclear symptoms need medical review whatever the client is taking; manufacturers' leaflets say the same [source: DHU leaflet].
• No conflicts of interest. No product, course or affiliate links; disclose and manage any personal involvement [APA 3.05, 3.06].
• Children and vulnerable people get a lower threshold for concern [synthesis].
• Record it. Document use, discussion, information given and decisions [synthesis; APA 3.10].

4. Intervention inventory

All interventions below are the psychotherapist's own work alongside a client's use of Schüßler salts. None involves choosing, supplying or endorsing a salt. Unless a source is cited, the procedure is [synthesis] from general clinical practice; no Schüßler organisation publishes guidance for psychotherapists [uncertain: not verified].

4.1 Routine, non-judgemental inquiry and recording

• Purpose / when: At intake and at reviews, so that complementary use is known and can be coordinated. Many clients do not volunteer over-the-counter products because they are sold as gentle or "just minerals" [synthesis].
• Steps: (1) Ask a general question covering medicines, supplements and complementary products. (2) If Schüßler/tissue/cell salts are named, record: which numbers or products, who advised (self, pharmacy, Heilpraktiker, online, friend), what for, since when, monthly cost. (3) Ask whether their doctor and pharmacist know. (4) Ask whether anyone else in the household, especially children, is given them. (5) Note the client's attitude (curious, committed, ambivalent) without comment.
• Example language (illustrative): "Lots of people use things alongside regular medicine – supplements, homeopathic or Schüßler salts, herbal teas. Is there anything like that you use? I ask everyone, so we have the full picture."
• Watch for: Defensiveness (signals expected disapproval; soften), use for symptoms that have never been medically assessed, use by children, large spending. Working: the client answers openly and later updates you unprompted.

4.2 Exploring meaning, hopes and the explanatory model

• Purpose / when: After use is disclosed, to understand what the salts do for the client psychologically – control, hope, a gentle self-care ritual, distrust of medicine, family tradition, identity or belonging (e.g. a local biochemical association) [synthesis].
• Steps: (1) Ask what they understand the salts to do, in their own words (e.g. "a mineral imbalance in my cells"). (2) Ask what drew them and what they hope will change. (3) Ask how they will know if it is working, and what they would do if it did not. (4) Ask about experiences with conventional care that shaped the choice. (5) Reflect the values you hear (self-reliance, gentleness, avoiding side effects). (6) Note any rigid or catastrophic beliefs about illness or medicine for later work.
• Example language (illustrative): "In Schüßler's way of thinking, symptoms come from a mineral imbalance. What does that explanation give you that other explanations haven't?" / "If in a couple of months nothing had changed, what would that mean to you?"
• Watch for: Salts used as a substitute for help-seeking that feels frightening; magical thinking linked to OCD or health anxiety; grief or anger towards medicine after past harm. Working: the client can describe their hopes and limits, and links the choice to their values.

4.3 Supporting informed, values-based decisions

• Purpose / when: When the client is deciding whether to use salts instead of, alongside or after medical assessment, or asks your view. No published decision aid specific to Schüßler salts is known [uncertain: not verified].
• Steps: (1) Ask permission before giving information. (2) Give the status as public bodies state it, attributed: registered homeopathic medicines in Germany sold without a stated indication [source: DHU leaflet]; no recognised clinical study showing an effect [source: Apotheken Umschau; BARMER]; manufacturers' leaflets say to see a doctor for persistent, unclear, new or worsening complaints [source: DHU leaflet]. (3) Separate two questions: "Do I take the salts?" (client's choice) and "Do I get my symptoms assessed?" (strongly encouraged). (4) Use a simple pros/cons/values grid drawn up by the client. (5) Agree personal "review triggers" – signs that would send them to a doctor. (6) Record the information given and the client's decision.
• Example language (illustrative): "It's your decision whether you take them. What I'd like us to be clear on is what would tell you it's time to get a doctor to look at this, whatever you're taking."
• Watch for: Your own persuasion creeping in (client goes quiet or argues) – return to their values; decisions made under pressure from a seller or group. Working: the client states their own reasons and review triggers.

4.4 Coordination with the client's doctor or pharmacist

• Purpose / when: When the client takes prescribed medicines, has an unassessed or chronic symptom, is pregnant or breastfeeding, gives salts to a child, or has diabetes, sugar intolerance or wheat allergy (tablets contain lactose and wheat starch; leaflets advise consulting a doctor with known sugar intolerance and warn of wheat-starch hypersensitivity) [source: DHU leaflet].
• Steps: (1) Explain why coordination helps. (2) Obtain specific written consent (what, to whom). (3) Prefer client-led disclosure first ("Can you mention it at your next appointment?"); offer a short letter if needed. (4) In a letter, state facts only: product type, reported use, your clinical concern; no advice on the product. (5) Follow up on what happened. (6) Document consent and contacts.
• Example language (illustrative): "The leaflet itself says to ask your doctor in pregnancy and with sugar intolerance. Would you be willing to mention it to her, or would you like me to send a short note?"
• Watch for: Fear of being judged by the doctor (rehearse the conversation); refusal (respect, document, keep the door open unless risk requires otherwise). Working: the prescriber/pharmacist knows and the client feels supported rather than reported.

4.5 Recognising and responding to delayed or replaced medical care

• Purpose / when: Highest-priority risk. Unofficial online lists name serious conditions such as stroke and angina; a German health magazine warns that letting a tablet dissolve during a stroke instead of calling emergency services "can end badly" (paraphrased) [source: Apotheken Umschau]. Stiftung Warentest is reported as warning that needed treatment may start late or not at all [source: GWUP, secondary report].
• Steps: (1) Screen for emergency symptoms (chest pain, stroke signs, breathing difficulty, high fever in infants, suicidal crisis); if present, direct to emergency services now. (2) Ask whether any symptom has not been medically assessed or whether prescribed treatment has been stopped or replaced. (3) Express concern clearly and specifically, separating the salts from the need for assessment. (4) Agree a concrete next step and date. (5) Escalate per your safeguarding/duty-of-care policy if capacity is in question or a dependant is at risk.
• Example language (illustrative): "I'm not asking you to stop anything. I am worried that this pain hasn't been checked by a doctor. Could we work out today how you'll get it looked at?"
• Watch for: Statements that the doctor "only treats symptoms"; stopping a prescribed medicine on a practitioner's advice (route to the prescriber, do not advise yourself); interpreting worsening as an "initial aggravation" – leaflets say to stop and ask a doctor if complaints worsen [source: DHU leaflet]. Working: assessment booked and attended.

4.6 Children, pregnancy and breastfeeding

• Purpose / when: When a parent gives salts to a child, or a client is pregnant or breastfeeding. Leaflets say to ask a doctor before using any medicine in pregnancy or breastfeeding and to keep medicines out of children's reach [source: DHU leaflet]. Pharmacy-staff trainings include child and pregnancy topics, so parents may be actively advised to use salts [source: apotheke adhoc].
• Steps: (1) Ask what the child is given, for what, and whether the paediatrician has seen the problem. (2) Ask about the child's own view (assent) where age-appropriate. (3) Encourage medical assessment of any persistent or worrying symptom. (4) If a child is being deprived of necessary medical care, escalate under your local child-protection procedures; the salts themselves are not the safeguarding issue, the missed care is [synthesis]. (5) In pregnancy, route all product questions to the midwife, doctor or pharmacist.
• Example language (illustrative): "Has his doctor had a look at the cough? Whatever you decide about the salts, I'd want him seen if it carries on."
• Watch for: Fever, breathing difficulty, dehydration or failure to thrive treated only at home; parental fear of medicine rooted in past events. Working: the child is medically reviewed and the parent remains engaged with you.

4.7 Eating, weight and "detox" framings

• Purpose / when: Some descriptions frame individual salts around metabolism or "Entschlackung" (detoxification) [source: apotheken.de], and a 2015 pharmacy training module covered metabolism and weight loss [source: apotheke adhoc]. Clients with restrictive, orthorexic or compensatory eating may use such framings to justify restriction [synthesis].
• Steps: (1) If salts are used for weight, "cleansing" or appetite, screen for eating-disorder features using your usual validated screen and clinical interview. (2) Explore the function of the purity or detox belief. (3) If an eating disorder is suspected, refer for medical assessment and specialist care (cross-ref Domain II). (4) Do not debate the salts; focus on eating behaviour and its risks.
• Example language (illustrative): "You mentioned using them to 'clear out' your system. Can you tell me more about what eating has been like lately?"
• Watch for: Rigid food rules, weight loss, compensatory behaviours, distress when routines are disrupted. Working: the client accepts assessment and talks about eating rather than products.

4.8 Financial, commercial and group pressure

• Purpose / when: When spending is significant, a seller or practitioner pushes many products or combinations, the client is drawn into paid courses or certification, or a group frames doubt as disloyalty. Commercial trainings exist, some run with manufacturers [source: apotheke adhoc].
• Steps: (1) Ask about monthly cost and who profits from advice. (2) Ask whether they feel free to stop or to see a doctor. (3) Explore any pressure from a group or seller and its effect on relationships. (4) Problem-solve around budgets and boundaries. (5) Where misleading advertising is involved, give reporting routes (4.12).
• Example language (illustrative): "How much are you spending in a month, roughly? And does the person advising you also sell what they advise?"
• Watch for: Debt, secrecy, isolation from people who disagree, fear of leaving a group. Working: the client can name the pressure and make choices independently of it.

4.9 Face reading (Antlitzanalyse) and appearance concerns

• Purpose / when: When the client has been told that facial colour, lines or features show a deficiency [source: Apotheken Umschau; GWUP]. Clients with body dysmorphic concerns or health anxiety may scrutinise their face for "signs" [synthesis].
• Steps: (1) Ask what they were told and how it felt. (2) Ask whether they now check their face, and how often. (3) If checking or reassurance-seeking is increasing, formulate it as a safety behaviour and treat with standard CBT for BDD or health anxiety (Domain II). (4) Do not offer your own reading of their face.
• Example language (illustrative): "Since the practitioner pointed out the shadows under your eyes, have you found yourself checking the mirror more?"
• Watch for: Mirror checking, camouflage, avoidance. Working: checking falls and the client's attention returns to valued activity.

4.10 Health anxiety, somatic symptom presentations and idiopathic environmental intolerance

• Purpose / when: When salt use is part of a cycle of symptom monitoring, reassurance-seeking or fear of illness, or when the client attributes multiple unexplained symptoms to "deficiencies" [synthesis].
• Steps: (1) Ensure appropriate medical assessment has occurred, coordinated with the GP to avoid repeated testing. (2) Build a shared formulation (attention, interpretation, safety behaviours including remedy-taking as reassurance). (3) Use established approaches for health anxiety and somatic symptom disorder from Domain II (cognitive-behavioural formulation, reducing checking and reassurance, behavioural experiments, graded return to activity). (4) Treat remedy use the same way as any other safety behaviour: explored, not forbidden.
• Example language (illustrative): "When the worry spikes, what do you do first? Taking a tablet, checking, looking things up? Let's see what each does to the worry over the next hour."
• Watch for: Escalating product use, new "deficiency" explanations for each symptom, doctor shopping. Working: less checking, more tolerance of uncertainty, fewer urgent appointments.

4.11 Managing your own scope and conflicts of interest

• Purpose / when: Always, and especially if you personally use salts or have contacts in the field.
• Steps: (1) Do not sell, supply, recommend or refer to sellers; no affiliate links. (2) Do not perform face analysis or salt selection even if trained, as this is outside psychotherapy scope [APA 2.01]. (3) Decline or manage roles where personal or financial interests could impair judgement [APA 3.06]; avoid multiple relationships with practitioners treating your client [APA 3.05]. (4) Keep personal opinions out; base statements on cited sources [APA 2.04]. (5) Seek supervision when your own views are strong.
• Example language (illustrative): "That's outside what I do as your therapist – the person to ask about products is your pharmacist. What I can help with is how you're making the decision."
• Watch for: Pull to advise or to debunk; client asking you to choose. Working: the client experiences you as neutral and safe.

4.12 Reporting routes

• Purpose / when: Misleading health claims, adverse reactions, product-quality problems, or professional misconduct.
• Steps / routes:
  • UK: misleading promotion of tissue/Schüssler salts as medicines can be raised with the MHRA, which has acted on such complaints [source: MHRA 2015]; adverse reactions via the Yellow Card scheme [uncertain: not verified].
  • USA: FDA provides a route to report a product problem [source: FDA guidance page]; advertising complaints to the FTC [uncertain: not verified].
  • Germany: suspected adverse reactions to medicinal products to the federal medicines authority (BfArM), or via doctor or pharmacist [uncertain: not verified].
  • Practitioners: the relevant professional or licensing body (e.g. for doctors, pharmacists; in Germany Heilpraktiker are supervised by local health authorities) [uncertain: not verified].
  • Children deprived of necessary care: local child-protection services under your jurisdiction's procedures.
• Example language (illustrative): "If you think the advert misled you, there is a regulator you can tell. Would you like to look at that together?"
• Watch for: Breaching confidentiality: report with consent unless law or safeguarding requires otherwise [APA 4.05]. Working: concern lodged, client feels agency rather than blame.

4.13 Documentation and review

• Purpose / when: Every time complementary use is discussed.
• Steps: Record products/sources, the client's reasons, information given (with source), consent to coordination, risks screened, decisions and agreed review triggers; revisit at planned reviews or when symptoms change [synthesis; APA 3.10].
• Example language (illustrative): "I'll note that we talked about this and what you've decided, so we can come back to it."
• Watch for: Notes that read as judgement; write neutrally. Working: any colleague can see what was discussed and why.

5. Handling problems

The Schüßler sources address none of these therapist-side problems; all guidance below is [synthesis] unless a source is cited.

• Client asks "Do you think they work?" Ask what prompts the question, then give the attributed status briefly (no recognised clinical study showing an effect [source: Apotheken Umschau; BARMER]) and return to their decision and review triggers. Avoid both endorsement and ridicule.
• Client wants you to choose a salt or read their face. Decline warmly, name your scope, redirect to the pharmacist for product questions and to the doctor for symptoms (4.11).
• Defensiveness or rupture after you raise risk. Acknowledge the impact ("That came across as criticism"), repair, restate respect for their choice, and narrow your concern to the specific symptom or child. Use standard rupture-repair: name it, own your part, invite their view.
• Client stops or avoids prescribed medicine on a practitioner's advice. Do not advise on the medicine. Express concern, ask permission to involve the prescriber, and support the client to speak to them promptly; escalate if risk is high and capacity in doubt.
• Worsening reframed as "initial aggravation" or healing. Point to the leaflet's own advice to stop and consult a doctor if complaints worsen [source: DHU leaflet]; agree a medical review.
• Stuck in reassurance loops (health anxiety). Shift from content (does the salt work?) to process (what happens to the worry after taking it?); follow Domain II health-anxiety protocols.
• Non-adherence to coordination plans. Explore barriers (fear of judgement, past medical trauma, cost, access); rehearse the conversation; offer a letter; document informed refusal.
• Family conflict over use (e.g. partners disagree about a child). Hold a neutral, child-focused stance; focus on shared goals (the child's health) and on medical review; safeguarding if necessary care is withheld.
• Grief or regret after delayed care. Validate the reasons for the choice at the time; work with self-blame using standard grief and guilt interventions; avoid "I told you so" framings.
• Your own strong views. Use supervision; check notes for judgemental language; return to the client's values.
• Lactose, wheat starch or diabetes concerns raised by client. Do not advise on the product; leaflets direct people with sugar intolerance to consult a doctor and note wheat starch may contain small amounts of gluten [source: DHU leaflet]; route to pharmacist or doctor.
• Client distressed by critical media coverage or by a practitioner's claims. Help them hold uncertainty and make a decision that fits their values; offer accurate sources rather than opinion.

Sources

Web sources:

• Mit Salzen heilen – PTAheute (2021)
• GWUP brochure: Schüßler-Salze (sceptics' organisation; used for history and as a secondary report of Stiftung Warentest and Cochrane Österreich)
• Biochemie nach Schüßler – apotheken.de
• DHU Schüßler-Salz Nr. 1 package leaflet (pharmacy-hosted PDF)
• Borchardt: Die "Biochemische Heilkunst" des Dr. Wilhelm Schüssler, in Reichling, Müller-Jahncke, Borchardt (eds.), Arzneimittel der komplementären Medizin, Govi-Verlag, 2001, pp. 63–70 (publisher extract)
• Salz! Oder doch Zucker?! – Apotheken Umschau (2022)
• "PTA Schüßler-Salze" Fachberater (IHK) – apotheke adhoc (2015)
• BARMER: Was sind eigentlich Schüßler Salze? (2020)
• MHRA advertising investigations, November 2015: websites advertising homeopathic medicines
• FDA: Homeopathic Drug Products – Guidance for FDA Staff and Industry (December 2022)
• APA Ethical Principles of Psychologists and Code of Conduct (standards 2.01, 2.04, 3.04, 3.05, 3.06, 3.09, 3.10, 4.05)

Books and primary texts cited via the above [uncertain: not verified directly]:

• Schüßler, W. H. (1873). Eine abgekürzte Therapie, gegründet auf Histologie und Cellularpathologie. Allgemeine Homöopathische Zeitung [as reported by GWUP and Govi chapter; later editions not verified].